EVAX

Evaxion Biotech AS (EVAX)

Evaxion Biotech AS

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:EVAX

1 2 3 4 5 6 7 8 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/30	22:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS
2024/12/30	22:00	GlobeNewswire Inc.	Evaxion announces plan to implement ADS ratio change	NASDAQ:EVAX	Evaxion Biotech AS
2024/12/27	06:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS
2024/12/18	07:09	Edgar (US Regulatory)	Form F-1/A - Registration statement for certain foreign private issuers: [Amend]	NASDAQ:EVAX	Evaxion Biotech AS
2024/12/17	22:16	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS
2024/12/17	22:00	GlobeNewswire Inc.	Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equity	NASDAQ:EVAX	Evaxion Biotech AS
2024/12/12	22:10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS
2024/12/12	22:00	GlobeNewswire Inc.	Evaxion establishes new AI-derived precision cancer vaccine concept	NASDAQ:EVAX	Evaxion Biotech AS
2024/12/09	23:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS
2024/12/09	22:00	GlobeNewswire Inc.	Evaxion announces 2025 milestones reflecting continued strong strategy execution	NASDAQ:EVAX	Evaxion Biotech AS
2024/12/06	06:53	Edgar (US Regulatory)	Form F-1/A - Registration statement for certain foreign private issuers: [Amend]	NASDAQ:EVAX	Evaxion Biotech AS
2024/12/03	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS
2024/12/02	22:00	GlobeNewswire Inc.	Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress	NASDAQ:EVAX	Evaxion Biotech AS
2024/11/19	06:30	Edgar (US Regulatory)	Form F-1 - Registration statement for certain foreign private issuers	NASDAQ:EVAX	Evaxion Biotech AS
2024/11/13	23:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS
2024/11/13	22:00	GlobeNewswire Inc.	Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listing	NASDAQ:EVAX	Evaxion Biotech AS
2024/11/13	21:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS
2024/11/13	21:04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS
2024/11/12	22:00	GlobeNewswire Inc.	Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1	NASDAQ:EVAX	Evaxion Biotech AS
2024/10/31	23:20	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS
2024/10/31	21:00	GlobeNewswire Inc.	Evaxion announces business update and third quarter 2024 financial results	NASDAQ:EVAX	Evaxion Biotech AS
2024/10/28	22:10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS
2024/10/28	21:00	GlobeNewswire Inc.	Evaxion to announce business update and third quarter 2024 financial results on October 31	NASDAQ:EVAX	Evaxion Biotech AS
2024/10/10	00:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS
2024/10/09	21:00	GlobeNewswire Inc.	Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials	NASDAQ:EVAX	Evaxion Biotech AS
2024/10/04	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS
2024/10/03	21:00	GlobeNewswire Inc.	Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platform	NASDAQ:EVAX	Evaxion Biotech AS
2024/10/03	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS
2024/10/02	05:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS
2024/09/26	21:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS